PPARA and metabolic dysfunction-associated steatotic liver disease: As shown in Figure 7(Ad), the expression of the PPARα gene in the liver in the model group compared with the control group suggested that the HFHSD blocked the lipid oxidation pathway in the NAFLD mice.